Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.

@article{Shafer2007AntibodyAP,
  title={Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.},
  author={Michael W Shafer and Leslie A. Mangold and Alan W. Partin and Brian B. Haab},
  journal={The Prostate},
  year={2007},
  volume={67 3},
  pages={255-67}
}
BACKGROUND Blood protein markers that provide more accurate or earlier diagnosis of prostate cancer should have a positive impact on prostate cancer treatment and management. METHODS Serum samples from control subjects and patients with benign or malignant prostatic disease were analyzed on antibody arrays targeting multiple candidate prostate cancer markers and detected with two-color, rolling-circle amplification (TC-RCA). The measurements of certain antibodies were validated using… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

Validation of serum protein profiles by a dual antibody array approach.

Journal of proteomics • 2009
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…